Real-time in vivo imaging of surface-modified liposomes to evaluate their behavior after pulmonary administration

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 86, Issue 1, 2014, Pages 115-119

  Murata, Mitsutaka ^a   Tahara, Kohei ^a   Takeuchi, Hirofumi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

In vivo imaging; Indocyanine green; IVIS ; Liposomal surface modification; Pulmonary drug delivery; PVA

Indexed keywords

INDOCYANINE GREEN; LIPOSOME; POLYVINYL ALCOHOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LIPOSOMAL DELIVERY; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; PARTICLE SIZE; RAT; SURFACE PROPERTY; ZETA POTENTIAL;

IN VIVO IMAGING; INDOCYANINE GREEN; IVIS®; LIPOSOMAL SURFACE MODIFICATION; PULMONARY DRUG DELIVERY; PVA;

ANIMALS; COLORING AGENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOCYANINE GREEN; LIPOSOMES; LUNG; MALE; MOLECULAR IMAGING; PARTICLE SIZE; PEPTIDES; PHOSPHATIDYLCHOLINES; POLYVINYL ALCOHOL; RATS; RATS, WISTAR; SPECTROSCOPY, NEAR-INFRARED; SURFACE PROPERTIES; TISSUE DISTRIBUTION;

EID: 84896726188     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.09.006     Document Type: Article

References (24)

1. J.S. Patton, and P.R. Byron Inhaling medicines: delivering drugs to the body through the lungs Nat. Rev. Drug. Discov. 6 2007 67 74
2. H.M. Mansour, Y.-S. Rhee, and X. Wu Nanomedicine in pulmonary delivery Int. J. Nanomed. 4 2009 299 319
3. C. Beck, L. Sievens-Figueroa, K. Gärtner, J.I. Jerez-Rozo, R.J. Romañach, E. Bilgili, and R.N. Davé Effects of stabilizers on particle redispersion and dissolution from polymer strip films containing liquid antisolvent precipitated griseofulvin particles Powder Technol. 236 2013 37 51
4. Y.-Y. Huang, and C.-H. Wang Pulmonary delivery of insulin by liposomal carriers J. Control. Release 113 2006 9 14
5. H. Adi, P.M. Young, and D. Traini Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers J. Pharm. Pharmacol. 64 2012 1245 1253
6. N. Vij Synthesis and evaluation of airway targeted PLGA nanoparticles for drug delivery in obstructive lung diseases Methods Mol. Biol. 906 2012 303 310
7. J.C. Waldrep, C.M. Knight, M.B. Black, B.E. Gilbert, V. Knight, W. Eschenbacher, and P.W. Scherer Pulmonary delivery of beclomethasone liposome aerosol in volunteers: tolerance and safety Chest 111 1997 316 323
8. P. Zarogoulidis, E. Chatzaki, K. Porpodis, K. Domvri, W. Hohenforst-Schmidt, E.P. Goldberg, N. Karamanos, and K. Zarogoulidis Inhaled chemotherapy in lung cancer: future concept of nanomedicine Int. J. Nanomed. 7 2012 1551 1572
9. B.L. Laube The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination Respir. Care 50 2005 1161 1176
10. M. Sakagami, and P.R. Byron Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy Clin. Pharmacokinet. 44 2005 263 277
11. G. Kaur, R. Narang, G. Rath, and A.K. Goyal Advances in pulmonary delivery of nanoparticles Artif. Cells Blood Substit. Biotechnol. 40 2012 75 96
12. S. Chono, H. Suzuki, K. Togami, and K. Morimoto Efficient drug delivery to lung epithelial lining fluid by aerosolization of ciprofloxacin incorporated into PEGylated liposomes for treatment of respiratory infections Drug Dev. Ind. Pharm. 37 2011 367 372
13. E. Karathanasis, R. Bhavane, and A.V. Annapragada Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats J. Control. Release 113 2006 117 127
14. M.M. Bailey, and C.J. Berkland Nanoparticle formulations in pulmonary drug delivery Med. Res. Rev. 29 2009 196 212
15. A.M. Elhissi, M. Faizi, W.F. Naji, H.S. Gill, and K.M. Taylor Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures Int. J. Pharm. 334 2007 62 70
16. M. Murata, K. Nakano, K. Tahara, Y. Tozuka, and H. Takeuchi Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers Eur. J. Pharm. Biopharm. 80 2012 340 346
17. K. Licha, and C. Olbrich Optical imaging in drug discovery and diagnostic applications Adv. Drug Deliv. Rev. 57 2005 1087 1108
18. R. Reul, N. Tsapis, H. Hillaireau, L. Sancey, S. Mura, M. Recher, J. Nicolas, J.-L. Coll, and E. Fattal Near infrared labeling of PLGA for in vivo imaging of nanoparticles Polym. Chem. 3 2012 694 702
19. T. Mizuno, K. Mohri, S. Nasu, K. Danjo, and H. Okamoto Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence J. Control. Release 134 2009 149 154
20. H. Takeuchi, H. Kojima, H. Yamamoto, and Y. Kawashima Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats J. Control. Release 68 2000 195 205
21. S.T. Proulx, P. Luciani, S. Derzsi, M. Rinderknecht, V. Mumprecht, J.-C. Leroux, and M. DetmarProulx Quantitative imaging of lymphatic function with liposomal indocyanine green Cancer Res. 70 2010 7053 7062
22. S. Chono, T. Tanino, T. Seki, and K. Morimoto Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification J. Pharm. Pharmacol. 59 2010 75 80
23. K. Nakano, Y. Tozuka, and H. Takeuchi Effect of surface properties of liposomes coated with a modified polyvinyl alcohol (PVA-R) on the interaction with macrophage cells Int. J. Pharm. 354 2008 174 179
24. G.R. Cherrick, S.W. Stein, C.M. Leevy, and C.S. Davidson Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction J. Clin. Invest. 39 1960 592 600